Hong Kong Q3 2025 ECM Update: Chinese Companies Go Global
Johnson_Chui_200x200
Head of Global Issuer Services
Oct 17, 2025
In Q3 2025, Hong Kong solidified its position as the leading IPO fundraising hub in the world thanks to mega-IPOs and robust fundraising by Chinese companies expanding internationally. Johnson Chui, HKEX Head of Global Issuer Services, explains how.
Key Takeaways
#1
With US$23.9bn raised YTD from 66 IPOs at the end of Q3 2025, Hong Kong ranks as the leading IPO fundraising hub in the world.
#2
Several US$1bn+ IPOs have listed, including Zijin Gold International's US$3.2bn IPO1 in September 2025 – the second largest globally YTD – following CATL's US$5.3bn Hong Kong listing in May.
#3
Follow-on issuance in Hong Kong totalled US$58.5bn YTD at the end of Q3 2025, with 11 US$1bn+ transactions across equity placements, convertible and exchangeable bonds.
#4
International investors are the key liquidity providers in this growing market, with broad participation from long-only and private equity, to strategic, hedge fund and sovereign wealth funds underscoring HKEX’s standing as a global platform and Hong Kong’s position as a leading international finance centre.
#5
Chinese companies are increasingly using Hong Kong’s capital markets as a springboard for global expansion, and Zijin Gold International’s recent IPO consisted of a carve out of international assets specifically for listing in Hong Kong.
#6
Hong Kong’s IPO pipeline remains robust, with around 300 active A1 filings, including 32 under Chapter 18A and 16 under 18C Specialist Technology, and five listing applications from international companies, as of 5 October 2025.
Hong Kong’s IPO market: global leadership

 

Hong Kong’s capital markets sustained strong momentum in Q3 2025, maintaining their position as the no. 1 IPO fundraising hub in the world.

As of the end of Q3 2025, Hong Kong listings have raised US$23.9 billion this year across 66 IPOs2, up 192% and 45% YoY, respectively, compared to the same period in 2024 and US$5 billion more in IPO fundraising than the second leading exchange.

IPOs from companies in TMT, new energy, healthcare and consumer sectors have featured prominently. Average Hong Kong aftermarket performance has been strong over both the short-and medium-term, with jumbo transactions particularly standing out.

 


Robust follow-on fundraising

Placements, convertible and exchangeable bonds have buoyed follow-on issuance, with 11 US$1 billion+ transactions across a range of products driving US$58.5 billion of follow-on fundraising YTD at the end of Q3 2025 (up 172% YoY), accounting for an estimated 52% of total fundraising in Hong Kong.

This momentum reflects deep liquidity that has seen multiple issuers return to the public markets several times this year, with placements frequently larger than IPOs – highlighting liquidity depth, supportive market dynamics and an “issuer friendly” framework that streamlines post listing capital raising.

With US$19.1 billion of volume YTD, total convertible / exchangeable bond issuance has already broken records for annual fundraising in the category, with several US$1 billion+ transactions recorded this year.


Placements account for close to half of ECM activity in Hong Kong YTD in 2025

 

 

 

Looking at the full suite of ECM products, Hong Kong ended Q3 as the number three listing venue, with US$82 billion in total capital raised as of the end of September 2025.

Chinese firms going global

Firms from the Chinese Mainland are increasingly using Hong Kong’s capital markets to fund international expansion, fueling a surge in fundraising activity.

Publicly released data show that for 2025 YTD, half of all these IPO issuers generate significant revenue outside the Chinese Mainland, and funds raised by these issuers account for around 80% of IPO fundraising in Hong Kong. 

These developments underscore a strategic push to move beyond exports and build internationally.

China’s global value chain has evolved: today’s champions export not just products, but innovation and advanced technology. Chinese firms are now building overseas R&D and production hubs, setting new standards for innovation in sectors like EV batteries and AI, and accelerating growth in new markets.


By localising supply, routing around tariffs and shortening logistics – especially in EVs and batteries – Chinese companies are diversifying supply chains and positioning production closer to end-markets.

Localising in priority markets such as Europe, South America and Southeast Asia secures tariff-free access and greater resilience to trade frictions, while overseas expansion also diversifies revenue and reduces dependence on the domestic cycle.

This approach also extends to consumer brands in beauty, lifestyle, and food tech which are investing in flagship stores, distribution networks and digital storefronts, tailoring products through overseas R&D and design hubs.

Amid all the fundraising activity, signs are emerging of a shift in how Chinese companies present themselves to investors. Whereas global conglomerates “carve out” their China operations to list in Hong Kong, some Chinese mainland corporates now are putting international assets into offshore vehicles for Hong Kong listings.


Hong Kong in the forefront

As Chinese enterprises accelerate their global expansion, Hong Kong’s international fundraising platform is the natural place to finance that ambition. Supported by rules protecting the free flow of international capital, the city offers access to deep, diversified pools of financing – from sovereign wealth funds to global asset managers – drawn from every major market.

International investor engagement has been particularly robust in 2025 with diverse investor participation from major investor categories including long-only, PE, strategic, hedge fund and sovereign wealth funds. The Zijin Gold International IPO is emblematic, with 26 global cornerstone investors – including high quality names from North America, Asia, Europe and the Middle East – anchoring around half of the bookbuild.

Looking ahead, the outlook for 2025 and into 2026 looks strong. The Hang Seng Index stands as the top performing equity index globally and is on track for its best annual gain since 2017. Year-to-date performance has been broad-based across sectors, with the Hang Seng Tech Index up 44.7%, Hang Seng Healthcare Index up 94.8% and Hang Seng Biotech Index up 104.6%, as of 30 September 2025. In addition, YTD ADT of HK$256.4 billion at the end of September 2025, up 126% compared with the same time period in 2024, underlines a healthy environment for fundraising.

As of 5 October 2025, there are around 300 active A1 filings, with 48 companies under the 18A and 18C regimes, and five listing applications from international companies currently on file. With attractive listing regimes, sector breadth and deep liquidity, Hong Kong is poised to maintain its position as the premier venue for IPOs and global fundraising for the foreseeable future.

 


 


 

  1. Zijin International's IPO raised US3.2 billion on the day of listing. Including the post-listing overallotment exercise, the total fundraise reached US$3.7 billion.
  2. IPO calculations exclude SPAC transactions.